Workshop A – Assessing the Impacts of and Planning for the New Administration
Time: 9:00 am - 12:00 pm
day: Pre-Conference $ Workshop Day
Details:
- Monitoring the impact of new HHS leaders for cell and gene therapy approvals
- What can you expect for IRA drug pricing provisions?
- How have pricing and reimbursement policies evolved thus far, and how are they likely to evolve in the coming years?
- What have been the immediate impacts on CGT pricing and reimbursement?
- Based on early learnings, how should drug manufacturers adapt to changes to ensure coverage and access to their therapies?
Speakers:
